Fineotex Chemical Limited will host an in-person plant visit for investors and analysts at its Ambernath facility in Maharashtra on September 11, 2026. The management has scheduled the interaction starting at 8:00 am.

Visit details

The company disclosed the schedule pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The visit aims to provide the investment community with direct access to the company’s operations. No price-sensitive information will be discussed or disclosed during the event.

The plant is located at B-24, Anand Nagar, Additional M.I.D.C., Ambernath, Maharashtra – 421506. The schedule is subject to change due to exigencies on the part of the analysts, institutional investors, or the company.

Participating firms

Fourteen investment firms have been invited for the visit. The list includes prominent names such as Electrum Capital, Burman Capital, and JM Financial.

Sunny Parmar, Company Secretary and Compliance Officer of Fineotex Chemical Limited, signed the intimation letter dated September 8, 2026.

Fineotex Chemical 's subsidiary, Fineotex Biotex Healthguard FZE, has incorporated Fineotex Holdings Inc. in Delaware, USA, as a wholly owned step-down subsidiary to explore specialty chemicals and other growth opportunities.

Corporate structure and strategic intent

The newly formed entity, Fineotex Holdings Inc., is established under the laws of Delaware, a jurisdiction widely used for corporate incorporations in the United States. The incorporation is carried out through Fineotex Biotex Healthguard FZE, making Fineotex Holdings Inc. a step-down subsidiary of Fineotex Chemical.

Key details of the new entity

The move expands Fineotex Chemical's international corporate footprint through its existing overseas subsidiary structure, with the Delaware-based entity positioned to pursue opportunities in specialty chemicals alongside other business areas.